Home » Stocks » PolyPid

PolyPid Ltd. (PYPD)

Stock Price: $15.29 USD -2.04 (-11.77%)
Updated Jul 6, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 203.30M
Revenue (ttm) n/a
Net Income (ttm) 6.91M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 6, 2020
Last Price $15.29
Previous Close $17.33
Change ($) -2.04
Change (%) -11.77%
Day's Open 17.50
Day's Range 14.44 - 18.00
Day's Volume 71,682
52-Week Range 14.44 - 19.45

More Stats

Market Cap 203.30M
Enterprise Value 176.32M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding n/a
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -32.42
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income -18.56M
Net Income 6.91M
Free Cash Flow -18.24M
Net Cash 26.98M
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC 45.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-18.56-18.36
Net Income6.91-5.92
Shares Outstanding0.560.56
Earnings Per Share-23.69-0.86
Operating Cash Flow-17.36-16.68
Capital Expenditures-0.88-3.07
Free Cash Flow-18.24-19.75
Cash & Equivalents26.987.55
Net Cash / Debt26.987.55
Book Value-87.63-81.71
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PolyPid Ltd.
Employees 57
CEO Amir Weisberg

Stock Information

Ticker Symbol PYPD
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: PYPD
IPO Date June 26, 2020


PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform. Its products include D-PLEX, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX100 for the prevention of post-abdominal surgery incisional infection; BONYPID-1000, an antibiotic eluting ß tri-calcium phosphate granule for bone related infections applications; and BONYPID–500, an antibiotic eluting bone graft substitute that fills and reconstructs periodontal and oral/maxillofacial defects, while protecting from infections. PolyPid Ltd. was founded in 2008 and is headquartered in Petach Tikva, Israel.